Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.830
-0.020 (-0.70%)
At close: Mar 6, 2026, 4:00 PM EST
2.650
-0.180 (-6.36%)
After-hours: Mar 6, 2026, 5:12 PM EST
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 10 employees as of December 31, 2024. The number of employees decreased by 3 or -23.08% compared to the previous year.
Employees
10
Change (1Y)
-3
Growth (1Y)
-23.08%
Revenue / Employee
n/a
Profits / Employee
-$1,293,360
Market Cap
6.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 37 |
| Theriva Biologics | 22 |
| XTL Biopharmaceuticals | 10 |
| Revelation Biosciences | 9 |
| Purple Biotech | 9 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Creative Medical Technology Holdings | 4 |
PCSA News
- 7 weeks ago - Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - GlobeNewsWire
- 2 months ago - Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data? - Benzinga
- 2 months ago - Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer - GlobeNewsWire
- 4 months ago - Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025 - GlobeNewsWire
- 7 months ago - Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies - GlobeNewsWire
- 8 months ago - Processa Pharmaceuticals Provides Portfolio and Business Update - GlobeNewsWire
- 9 months ago - Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering - GlobeNewsWire